Monday, September 29, 2008

eClinical Moves into the Mainstream

Date:9/11/2008
Length: 00:13:28
Size: 6.17MB

Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions

In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Fighting Back: Technology Solutions to the Counterfeit Drug Problem

Date: 9/22/2008
Length: 00:15:56
Size: 7.29MB
Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon

In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes

Date: 9/8/2008
Length: 00:14.49
Size: 6.78MB

Thought Leaders:
Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)

In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Thursday, September 11, 2008

Molecular Design and the Critical Path Problem

Date:9/08/2008
Length: 00:16:35
Size: 7.59MB

Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board

In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Play Podcast

Download free related whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.